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Abstract
Background: Epstein-Barr virus (EBV) associated nasopharyngeal cancer (NPC) is an important
squamous cell cancer endemic in Southeast Asia and the Far East and can be considered a
multifactorial genetic disease. This research explores potential associations between
nasopharyngeal epithelial EBV receptor and NPC susceptibility. To prove the hypothesis, we
evaluated two candidate genes, complement receptor 2 (CR2) and polymeric immunoglobulin
receptor (PIGR) by using 4 SNPs, CR2IVS2-848C→T, PIGRIVS3-156G→T,  PIGR1093G→A and
PIGR1739C→T, to genotype 175 cases and 317 controls, divided into Thai, Chinese and Thai-
Chinese based on their respective ethnic origins.
Results:  The results obtained indicated that PIGR  is an NPC susceptibility gene. The risk
association pertaining to each ethnic group was detected for homozygous PIGR1739C with a
significant ethnic group adjusted OR (95%CI) of 2.71(1.72–4.23) and p < 0.00001. Haplotype of the
two missense PIGR SNPs, 1093G→A and 1739C→T, and sequence analyses have confirmed the
role of the nucleotide PIGR1739 and excluded possibility of an additional significant nonsynonymous
NPC susceptibility SNP.
Conclusions: We present genetic evidence leading to hypothesize a possibility of PIGR to function
as the EBV nasopharyngeal epithelium receptor via IgA-EBV complex transcytosis failure. The
PIGR1739C→T is a missense mutation changing alanine to valine near endoproteolytic cleavage site.
This variant could alter the efficiency of PIGR to release IgA-EBV complex and consequently
increase the susceptibility of populations in endemic areas to develop NPC.
Background
Nasopharyngeal cancer (NPC [MIM 161550]) constitutes
an endemic multifactorial genetic disease [1]. Whereas the
disease is quite rare in the Western world, it occurs at high
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frequencies in Southern China, Southeast Asia, and
among the Greenland Inuit. The highest aged-adjusted in-
cidence has been reported in South China to be 30–50/
100,000. Intermediate incidence has been noted in South
East Asia with a ratio of 3/100,000 among Thais and 10/
100,000 among Thais of Chinese extraction, respectively
[2]. Regarding environmental carcinogenesis, both viral
and chemical carcinogens contribute to NPC with Epstein
Barr virus (EBV) as the most important etiological factor.
The single clonally derived viral genome can be found in
all endemic NPC cells [3–5]. On the other hand, several
reports indicate that consuming salty fish or preserved
food and thus concentrating chemical carcinogens such as
nitrosamine, can promote the development of NPC [6,7].
Interestingly, two NPC susceptibility genes, HLA and cyto-
chrome P450 2E1 (CYP2E1), were discovered based on
their hypothesized relationship with environmental fac-
tors contributing to NPC etiology. HLA was first studied in
Singapore as this gene would be responsible for patients'
immune response to cancer or EBV infected cells [8]. In
particular HLA A2 and B46 conferred a high relative risk
as to NPC development according to various reports in
Asia [9]. In addition, NPC development was proposed to
correlate with patients' history of consuming preserved
food and hence CYP2E1, which metabolises nitrosamine,
was studied revealing a risk association in Taiwan [10]
and Thailand [11]. This research aims at exploring the ge-
netic aspect of EBV entry into the nasopharyngeal epithe-
lium (NE). This process not only requires specific host
factors but also differentiates between the mechanisms of
EBV carcinogenesis originating in epithelial and/or lym-
phoid cells. Whereas EBV-associated Burkitt's lymphoma
is prevalent in Africa, populations demonstrating a higher
risk for developing NPC do not show any significant in-
crease in the lymphoma incidence [12].
The mechanism of EBV entry into the NE has not yet been
conclusively elucidated but at least two receptors, comple-
ment receptor type 2 (CR2) and polymeric immunoglob-
ulin receptor (PIGR), have been proposed. CR2 is an
integral membrane glycoprotein to which EBV can bind
and thus infect B-lymphocytes [13]. EBV can infect recom-
binant epithelial cells expressing CR2 especially when in
contact with virus-producing lymphocytes [14,15]. In ad-
dition, there has been a study reporting CR2 expression in
embryonic NE cell by RT-PCR [16]. As for PIGR, the pro-
tein can be discovered on NE, interestingly as a pneumoc-
cocus receptor, [17] where it mediates endocytosis and
transcytosis of IgA-EBV complexes to deliver EBV into the
luminal surface [18]. The viral translocation process can
fail and consequently cause EBV infection if the epitheli-
um loses its polarity or has mutated PIGR [19,20]. In ad-
dition to NE, EBV was reported to enter NPC in vitro
depending on the presence of viral specific IgA [21]. Inter-
estingly, serology studies indicate indirectly that PIGR is
involved in NPC development. High EBV-IgA titers can be
detected in a significant portion of NPC patients and the
test has significant predictive role in diagnosing the dis-
ease [22]. Based on specific endemic distribution, NPC
susceptibility genes can be hypothesized to originate from
ancestor alleles. Hence, this study has been designed can-
didate-gene approaches for studying complex genetic
traits [23]. The specific aim has been to explore whether
CR2 or PIGR might be NPC susceptibility genes by deter-
mining the risk association between their DNA polymor-
phisms and haplotypes among NPC patients and controls
from several individuals of high-risk ethnic origin.
Results
PIGR and CR2 SNPs NPC case-control study
The study explored the risk of association between CR2 or
PIGR DNA polymorphisms and NPC phenotype. Both the
175 patients and 317 controls were separated into Thai,
Chinese and Thai-Chinese, according to their grandpar-
ents' ethnic origin so that each group would have a higher
probability of shared ancestors. The genotype of four
SNPs,  CR2IVS2-848C→T,  PIGRIVS3-
156G→T,PIGR1093G→A and PIGR1739C→T, were in-
vestigated. CR2IVS2-848C→T located near exon 1, 2 [24],
and PIGRIVS3-156G→T in intron 3 [25], have previously
been published as RFLP polymorphisms. PIGR1093G→A
and PIGR1739C→T, on exon 5 and 7, respectively, were
selected from a SNP database http://www.nc-
bi.nlm.nih.gov/SNP/. PIGR1093G→A displays an amino
acid alteration from glycine to serine and PIGR1739C→T
from alanine to valine, respectively. No missense SNP
from CR2 has recently been reported by genbank. The am-
plicons of CR2IVS2-848C→T,  PIGRIVS3-156G→T and
PIGR1739C→T were genotyped by PCR-RFLP, and
PIGR1093G→A by ARMS (fig 1).
Upon comparison between the frequency of these alleles
in patients and controls of identical ethnic origin, Thai or
Chinese, a significant risk association to PIGR1739C→T
was detected but neither to PIGRIVS3-156G→T nor
PIGR1093G→A (table 1). The OR (95%CI) of
PIGR1739C→T in the Thai group was 1.70(1.03–2.82)
and 2.35(1.11–5.07) among Chinese NPC cases with
1739C as the susceptible allele. When we analyzed all
three ethnic groups and used Mantel-Haenszel stratifica-
tion method to correct for ethnic matched control, the dif-
ference between crude and adjusted OR of PIGR1739C→T
was less than 15%. The significant race adjusted OR
(95%CI) is 2.26(1.51–3.25) with the p value was less than
0.0001. The NPC susceptibility conferred by PIGR  re-
quires homozygous 1739C to increase the likelihood of
NPC development, with the race adjusted OR(95%) =
2.71(1.72–4.23) and p < 0.00001 (table 2). The similar
significant contribution can be demonstrated with all sub-
groups (table 2). Regarding CR2,  CR2IVS2-848C→TBMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/3
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demonstrated no considerable correlation with NPC
when analyzing Thai, Chinese or including all cases. Nev-
ertheless significant OR (95%CI) = 1.80(1.14–3.03) with
p < 0.05 could be demonstrated upon adjusting for age,
sex and ethnic of all cases (table 1). This data suggests that
the role of CR2 as an NPC susceptibility gene need further
evaluation while the role of PIGR is crucial.
Haplotype analysis of two missense PIGR SNPs, 1093 
G→A and 1739 C→T
To further elucidate the relevance of the two missense
SNPs as for NPC development, genotype data of
1093G→A and 1739C→T were tabulated into four haplo-
types, 1093G-1739T (GT), 1093G-1739C (GC), 1093A-
1739T (AT), and 1093A-1739C (AC) (table 3). The
Figure 1
SNPs analysis of CR2 and PIGR. (A) The CR2IVS2-848C→T was distinguishable by TaqI restriction. Digestion of the 1241 bp 
amplicon yielded two DNA fragments, 750 and 491 bp. Lane 1, 3 and 4 were homozygous -/- and lane 2 was heterozygous +/-. 
(B-D) PIGR polymorphisms was investigated by PCR-RFLP and ARMS. (B) RFLP analysis of 1392 bp PIGRIVS3-156G→T PCR 
products with PvuII digestion yielded 1163 and 229 bp DNA fragments. Lane 1,2,4,7 and 8 were heterozygous +/-, samples 3,9 
and 12 were homozygous +/+, and samples 5,6,10 and 11 were homozygous -/-. (C) RFLP of PIGR1739C of the 220 bp PCR 
product was analyzed by HgaI digestion and yielded two fragments of 180 and 40 bp, respectively, whereas 1739T remained as 
220 bp DNA product. Heterozygous CT yielded 220,180 and 40 bp fragments. Negative control in lane1; homozygous CC in 
lanes 2,5,7 and 8; heterozygous CT in lanes 3 and 6, and homozygous TT in lane 4. (D) PIGR1093G→A was detected by ARMS. 
Negative control in lanes 1 and 2 for primer sets A and B. Samples S1, 2, 3, were homozygous 1093G. Samples S4, 5, 6 were 
homozygous 1093A, and S7 was heterozygous.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/3
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frequency of each haplotype based on its ethnic group was
estimated by the EH program and distribution was com-
pared between groups. Among the controls, there were no
relevant difference between the Thai and the Chinese, yet
the p values for the cases and the controls of both sub-
groups and the total were below 0.05 and 0.005, respec-
tively (table 3).
Comparison among haplotypes confirmed 1739C→T as
NPC susceptible mutation and excluded any other
particular PIGR allele (table 3). First, whereas 1739C→T
did, no haplotype was associated with significant OR in
all Thai, Chinese and Thai-Chinese populations. Second,
there were haplotypes with 1739C as susceptible alleles
such as GC in the Chinese and total and 1739T as protec-
tive alleles such as AT in the Thai, GT in the Chinese and
both haplotypes in the total population. In addition,
there was no significant haplotype with 1739C as a pro-
tective allele or 1739T associated with significant higher
relative risk. Finally, the relationship between each haplo-
Table 1: CR2 and PIGR polymorphisms in NPC cases and control subjects.
THAI CHINESE TOTAL
case control case control case control
Number of tests 110 104 42 107 175 317
CR2IVS2-848C→T
+ / + 011122
+/- 34 20 7 21 48 63
-/- 76 83 34 85 125 252
+ allele frequency 0.15 0.11 0.11 0.11 0.15 0.11
Crude OR (95%CI) 1.55(0.84–2.85) 1.00(0.41–2.39) 1.48(0.98–2.22)1
Ethnic group adjusted OR (95%CI) 1.47(0.96–2.26)
age, sex and ethnic group adjusted OR (95%CI) 1.80(1.14–3.03)1
PIGRIVS3-156G→T
+/+ 32 30 9 42 49 114
+ / - 6 15 82 64 89 9 1 5 5
-/- 17 16 7 17 27 48
+ allele frequency 0.57 0.57 0.52 0.62 0.56 0.60
Crude OR (95%CI) 1.00(0.67–1.50) 0.68(0.40–1.17) 0.84(0.64–1.11)
Ethnic group adjusted OR (95%CI) 0.88(0.66–1.18)
Age, sex and ethnic group adjusted OR (95%CI) 0.93(0.67–1.29)
PIGR1093G→A
GG 53 48 17 52 79 142
GA 49 46 24 42 82 137
A A 81 011 3 1 4 3 8
G allele frequency 0.70 0.68 0.69 0.68 0.69 0.66
Crude OR (95%CI) 1.11(0.72–1.71) 1.04(0.58–1.86) 1.10(0.83–1.47)
Ethnic group adjusted OR (95%CI) 1.03(0.76–1.40)
Age, sex and ethnic group adjusted OR (95%CI) 0.96(0.68–1.36)
PIGR1739C→T
CC 79 58 32 60 132 170
CT 26 40 9 38 37 130
T T 56196 1 7
C allele frequency 0.84 0.75 0.87 0.74 0.86 0.74
Crude OR (95%CI) 1.70(1.03–2.82)1 2.35(1.11–5.07)1 2.14(1.49–3.09)3
Ethnic group adjusted OR (95%CI) 2.26(1.51–3.25)3
Age, sex and ethnic group adjusted OR (95%CI) 2.06(1.36–3.30)2
Total is Thai, Chinese and Thai-Chinese cases and controls. CR2IVS2-848C→T and PIGRIVS3-156G→T allele+ and allele- are digested and not 
digested with the restriction enzyme, respectively. G and A are nucleotide at PIGR1093, and C and T are nucleotide at PIGR1739, respectively. OR 
(95%CI) = odd ratios and 95% confidence interval of allele CR2+, PIGRIVS3-156G, PIGR1093G, PIGR1739C when compared with the other alleles of 
the same SNPs. 1 p < 0.05, 2 p < 0.001, 3 p < 0.0001BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/3
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Table 2: Risk of nasopharyngeal carcinoma associated with PIGR1739C→T genotype according to different models of inheritance.
THAI OR
(95%CI)
CHINESE OR
(95%CI)
TOTAL OR
(95%CI)
ETHNIC GROUP 
ADJUSTED
 OR (95%CI)
AGE, SEX AND ETHNIC 
GROUP
 ADJUSTED OR (95%CI)
C codominance, T wild 
type
CC 1.63(0.42–6.55) 4.80(0.57–105.53) 2.20(0.79–6.44) 2.59(0.85–7.48) 2.53(0.68–13.43)
CT 0.78(0.18–3.35) 2.13(0.22–50.65) 0.81(0.27–2.48) 1.08(0.34–3.53) 1.24(0.23–8.00)
TT 1.00 1.00 1.00 1.00 1.00
C dominance, T wild type
TT 1.00 1.00 1.00 1.00 1.00
CC or CT 1.29(0.33–5.04) 3.77(0.46–81.87) 1.60(0.58–4.62) 1.96(0.66–5.70) 1.99(0.51–10.40)
C recessive, T wild type
CT or TT 1.00 1.00 1.00 1.00 1.00
CC 2.02(1.10–3.17)1 2.51(1.05–6.09)1 2.65(1.73–4.08)3 2.71(1.72–4.23)3 2.42(1.51–4.29)2
CC and TT are the homozygous C and T at nucleotide 1739, respectively. CT is the heterozygous at nucleotide 1739. Total is Thai, Chinese and 
Thai-Chinese cases and controls. OR (95%CI) is odd ratios and 95% confidence interval between allele and compared allele, 1 p < 0.05, 2 p < 0.001, 
3 p < 0.00001
Table 3: Haplotype frequencies of PIGR1093–1739, crude OR and ethnic group adjusted OR.
Haplotype THAI CHINESE TOTAL ETHNIC 
GROUP 
ADJUSTED
case control case control case control
GC frequency 0.556169 0.525147 0.590097 0.447343 0.543478 0.451985
OR (95%CI) 1.13(0.76–1.68) 1.18(1.05–3.12) 1.37(1.04–1.79) 1.36(1.02–1.80)
GT frequency 0.148376 0.171968 0.100379 0.234900 0.043478 0.175374
OR (95%CI) 0.84(0.49–1.46) 0.35(0.14–0.80) 0.64(0.43–0.93) 0.55(0.37–0.84)
AC frequency 0.280194 0.224853 0.278951 0.286302 0.413043 0.283864
OR (95%CI) 1.34(0.85–2.13) 0.95(0.52–1.72) 1.23(0.91–1.66) 1.28(0.93–1.76)
AT frequency 0.015260 0.078032 0.030573 0.031455 0.000001 0.088777
OR (95%CI) 0.17(0.04–0.62) 1.10(0.22–4.85) 0.12(0.03–0.40) 0.26(0.09–0.63)
case vs case 0.085
case vs control <0.05a <0.05b <0.005c
control vs 
control
0.192
Each haplotype frequency was calculated by the Estimating Haplotype-frequencies (EH) software program23. Total is Thai, Chinese and Thai-Chi-
nese cases and controls. OR (95%CI) = odd ratios and 95% confidence interval between the tested haplotype and the other three alleles, The OR 
(95%CI) calculation used the estimated number from each haplotype number of cases and controls. The number of haplotypes in the total category 
were calculated from the summation of estimated haplotype number from each ethnic. GC, AC, GT, and AT are 1093G-1739C, 1093A-1739C, 
1093G-1739T, and 1093A-1739T haplotypes, respectively. Case vs case = p value comparing haplotype frequency between Thai case and Chinese 
case. Case vs control = p value comparing haplotype frequency between case and control in each ethnic. a is Thai, b is Chinese and c is total. Con-
trol vs control = p value comparing haplotype frequency between Thai control and Chinese control.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/3
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type was measured and the data obtained supported the
importance of 1739C→T (table 4). Whereas the ORs of
the same 1739 nucleotides, between GC and AC or GT
and AT, were not statistically significant, both GC and AC
haplotypes conveyed a higher OR than GT and AT.
PIGR sequences of NPC patients
By complete sequencing the coding region of the PIGR
gene from 16 NPC patients with homozygous 1739C and
upon comparison with the genomic DNA sequence
AC098935 and AL359089 as well as with PIGR SNPs re-
ported in genbank, the 2 SNPs at base pairs 1093 and
1739 were confirmed. No additional nonsynonymous
mutation was identified. However, there were six posi-
tions of new synonymous SNPs, IVS1-59G→A, IVS1-
35G→A, IVS4-3C→T, 373C→T, 549G→A, and
1773C→T.
Discussion
The SNPs and haplotypes case control association study
implicated that the probability to develop NPC might al-
tered by DNA variation of PIGR, with nucleotide 1739
playing this crucial part. PIGR has been assigned to 1q31
and comprises of 11 exons [18]. The 1093G→A and
1739C→T are located on exon 5 and 7, respectively. The
physical distance between nucleotide PIGRIVS3-156,
1093 and 1739 were 25 and 2.5 kb, respectively. Thus the
three SNPs were closely linked but they distinctly contrib-
uted to NPC development. Whereas PIGR1739C→T
exhibited a remarkably significant relative risk of NPC de-
velopment among all Thai and Chinese populations, as-
sociation of PIGRIVS3-156G→T and 1093G→A was not
shown. Our data have provided an example that conclu-
sions drawn from association studies aimed at identifying
a susceptibility gene without related functional SNP
should be interpreted with extreme caution [23]. If
1739C→T had not been chosen for this study, the impor-
tance of PIGR as an NPC susceptibility gene would have
been misconstrued.
The manner, in which this PIGR1739C→T alters cellular
movement of the IgA complex and consequently increases
the possibility of EBV associate NPC development, re-
mains to be elucidated. The polymorphism is a missense
mutation altering the amino acid alanine to valine. The
codon is located on exon 7, which is adjacent to the endo-
proteolytic cleavage site of the PIGR extracellular domain
[29,30]. As a result, homozygous 1739C of the PIGR of in-
dividuals from high-risk ethnic origin may alter efficiency
to release IgA-EBV complex and consequently, their NEs
would have higher possibility to be infected by EBV. Fu-
ture functional study is needed to elucidate how the poly-
morphisms in relationship with EBV biology alter the
NPC susceptibility.
It is important to note that the 1739C→T mutation can
also be found in other lower risk ethnic groups, such as
Caucasian [30]. Hence, this PIGR nucleotide, despite a re-
markably association with NPC, cannot account for its
unique endemic distribution. On the other hand, this
gene may be critical only for members of high-risk popu-
lations, to develop NPC as a consequence of other endem-
ic genetic and/or environmental risk factors. Additionally,
it is also interesting to find out whether the SNP on PIGR
is a risk-associated factor affecting the disease
susceptibility in the Caucasian population where NPC is
rare and not 100% EBV related.
PIGR plays a crucial role in mucosal immunity not only
against EBV, but also pneumococcal infection by facilitat-
ing transporting polymeric immunoglobulin transport
across the mucosal epithelium. Human PIGR can bind to
a major pneumococcal adhesion and enhanced pneumo-
coccal adherence and invasion [17]. In other words, two
important human pathogens, EBV and pneumococcus,
employ the same human antibody transport protein,
PIGR, to cause two common human diseases at the same
tissue type, NE. The manner in which these two organisms
interact with host (DNA) variation in vivo and what are
the consequences might be on a global evolutionary scale
will be very interesting subject for further investigation.
Table 4: Ethnic group adjusted odd ratios between each PIGR1093–1739 haplotype.
GC AC GT AT
GC 1.00 0.97(0.70–1.36) 1.93(1.24–2.91) 4.26(1.68–11.85)
AC 1.00 2.02(1.23–3.23) 4.31(1.76–13.18)
GT 1.00 2.18(0.83–7.34)
AT 1.00
Ethnic group adjusted odd ratios were calculated from the number of cases and controls of each haplotype in the first column by comparing with 
haplotype listed in the upper row. Numbers before () are odd ratios and within () are 95% confidence interval. GC, AC, GT, and AT are 1093G-
1739C, 1093A-1739C, 1093G-1739T, and 1093A-1739T haplotypes, respectively.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/3
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Conclusions
The aim of this research was to explore risk associations
between polymorphisms of two hypothesized nasopha-
ryngeal epithelial EBV receptors, CR2 and PIGR, and NPC
susceptibility The results obtained indicated that PIGR is
an NPC susceptibility gene. The risk association pertain-
ing to each ethnic group was detected for homozygous
PIGR1739C with a significant ethnic group adjusted OR
(95%CI) of 2.71(1.72–4.23) and p < 0.00001. This sug-
gested genetic evidence leading to hypothesize a possibil-
ity of PIGR as the epithelial receptor for EBV via IgA-EBV
complex transcytosis failure. More importantly, the
PIGR1739C→T is a missense mutation changing alanine
to valine near endoproteolytic cleavage site. This variant
could alter the efficiency of PIGR to release IgA-EBV com-
plex and consequently increase the susceptibility of popu-
lations in endemic areas to develop NPC.
Methods
Sample collection
After having obtained the subjects' informed consent as to
the purpose of the study blood samples were collected by
venipuncture from NPC patients and controls. The pa-
tients and controls were interviewed and then separated
into three groups, Thai, Chinese, and Thai-Chinese, re-
spectively, based on the ethnic origins of their grandpar-
ents. If their ancestors, including their great grandparents,
originated from China, they were considered Chinese. On
the other hand, if their ancestors originated from Thai-
land, they were defined as Thai. In addition, if their ances-
tors originated from Thailand and China, they were
defined as Thai-Chinese. Conclusively, 104 Thai, 107 Chi-
nese and 106 Thai-Chinese were enrolled in the control
group whereas the NPC patients comprised 110 Thai, 42
Chinese and 23 Thai-Chinese. The 175 patients were re-
cruited at King Chulalongkorn Memorial Hospital be-
tween 1994 and 2001. They were permanent residents in
Bangkok or the central part of Thailand. All cases were
Thai, Chinese or Thai-Chinese. The tumors of every pa-
tient was histologically ascertained as NPC type II or III,
according to WHO classification. The 317 controls were
healthy blood donors from Thai Red Cross Society, locat-
ing in the King Chulalongkorn Memorial Hospital. All
had permanent resident in Bangkok or the central part of
Thailand and those previously diagnosed with NPC or be-
longing to an ethnic group other than Thai, Chinese or
Thai-Chinese had been excluded. The male:female ratio
among the cases was 1.8:1 and among the controls 1.6:1,
respectively. Their DNA was isolated by proteinase K and
incubated overnight at 50°C, followed by phenol/chloro-
form extraction and ethanol precipitation.
SNP's information
Four SNPs, CR2IVS2-848C→T,  PIGRIVS3-
156G→T,PIGR1093G→A and PIGR1739C→T, were
chosen. CR2IVS2-848C→T located in intron 2 [24] and
PIGRIVS3-156G→T in intron3, [25] had previously been
published as RFLP polymorphisms, whereas PIGR1093
and PIGR1739 were selected from a SNPs database. http:/
/www.ncbi.nlm.nih.gov/SNP/
PCR-RFLP
PCR reactions were performed, using Perkin-Elmer/DNA
Thermal cycle480, in a total volume of 50 µl to amplify
CR2IVS2-848C→T,  PIGRIVS3-156G→T, and
PIGR1739C→T. The reaction mixtures consisted of 100 ng
of genomic DNA and the following set of primers at the
respective concentrations: 0.1 µM of CR2IVS2-848C→T
primers (5'-CTTTCTGTGCAGACCACGTT-3' and 5'-
GATCTATGGTAGCCAGTTGG-3'PIGRIVS3-156G→T
primers (5'-TCAGCCAGGGTAAGGATCC-3' and 5'-TGAT-
GGTCACCGTTCTGCC-3'), or 0.2 µM of PIGR1739C→T
primers (5'-GGGTCCCGCGATGTCAGCCTAG-3' and 5'-
TTCTCCGAGTGGGGAGCCTT-3'). The DNA samples
were amplified in the presence of 200 µmol dNTPs, 5 µl
of 10X PCR buffer (20 µM Tris-HCl pH 8.4, 50 mM KCl),
1.5 mM MgCl2 and 4U Taq DNA polymerase (Gibco). The
PCR condition for CR2IVS2-848C→T comprised an initi-
ation denaturation step at 94°C for 4 minutes, followed
by 35 cycles of 95°C for 1 minute, 55°C for 1 minute,
72°C for 2 minutes and final extension step at 72°C for 7
minutes. PIGRIVS3-156G→T was amplified 40 cycles at
an annealing temperature of 60°C for 1 minute, and ex-
tension at 72°C for 3 minutes. The conditions for
PIGR1739C→T was 35 cycles at 60°C annealing tempera-
ture for 1 minute and extension at 72°C for 1 minute.
Subsequently, RFLP analysis was performed on 20 micro-
liters each of the respective PCR products by subjecting
them to the following restriction enzymes (New England
Biolabs) at a 10U concentration: TaqI  for  CR2IVS2-
848C→T,  PvuII  for  PIGRIVS3-156G→T, and HgaI  for
PIGR1739C→T with overnight incubation at 65°C for
TaqI and at 37°C for both of PvuII and HgaI. The resulting
products were further analyzed by 2% agarose gel
electrophoresis.
ARMS of PIGR1093G→A
The Amplification Refractory Mutation System (ARMS)
[26] was used to detect SNP PIGR1093G→A. The primers
can be divided into 2 sets, A and B. Set A primers com-
prised of 1093Fa and 1093R (GCCCCACTGTGGTGAAG-
GGGGTGGCAGGTG and
ACTGGGCCTTAACCCACCCC), whereas 1093Fb
(GCCCCACTGTGGTGAAGGGGGTGG CAGGTA) and
1093R were mixed in set B. For each sample, the PCR re-
action was performed in duplicate, set A and B, in a total
volume of 50 µl containing 100 ng of genomic DNA, 1.5
mM MgCl2, 5 µl of 10X buffer (20 µM Tris-HCl pH 8.4, 50
mM KCl), 4U Taq Gold DNA polymerase (Perkin Elmer)
and 0.3 µM of primer set A or set B. PCR conditions in-BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/3
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cluded initial denaturation at 95°C for 10 minutes fol-
lowed by 30 cycles of 95°C for 1 minute, 65°C for 1
minute, 72°C for 1 minutes and final extension for 72°C
for 7 minutes in a Perkin-Elmer/DNA thermal Cycle 480.
Each SNP was investigated by 2% agarose gel electro-
phoresis for complementarity of the PCR product with the
3' nucleotide of primers set A and/or set B.
Statistical analysis
Both cases and controls were subdivided based on ethnic,
sex and age at sampling (i.e., <30, 30–49, 50–69, ≥ 70
years). The association between certain alleles of the CR2
or PIGR and NPC development was estimated by the stat-
calc from Epi info 2000 program http://www.cdc.gov/epi-
info/ to calculate the odds ratio (OR) and 95% confidence
interval (CI), Mantel-Haenszel chi squares and associated
p values. Mantel-Haenszel weighted OR, summary chi
square and p value were adjusted for the confounding ef-
fect of ethnic, and/or age and sex by combining stratified
2 × 2 tables. The effect exerted by genotype was estimated
as if autosomal inheritance according to actual number of
alleles contributed to a significant OR [27]. Haplotype fre-
quencies for pairs of alleles, as well as Chi square values
for allele associations were estimated by the Estimating
Haplotype-frequencies (EH) software program [28]. The
number of each haplotype from each ethnic were estimat-
ed based on the allele frequencies multiplied by the
number of cases. The haplotype numbers of all the cases
as well as controls were summation of the haplotype
numbers of Thai, Chinese and Thai-Chinese groups. The
association between each haplotype and NPC develop-
ment was calculated based on the OR using Epi info 2000
program. The haplotype differences between groups were
estimated by T(x2/2) = In(L, group1)+In(L, group2)-In(L,
group1+group2) as previously described [28].
Sequencing
All 11 exons of PIGR genomic DNA were amplified from
DNA samples of 16 unrelated patients. Each exon was am-
plified by a pair of primers locating on the following po-
sitions in relation with nucleotide number AL359089:
93732C-93751G and 94163A-93782C, 99668C-99687T
and 100025A-100044C, 100724C-100743T and
101427C-101446T, 102578A-102597G and 103454C-
103473A, 104403C-104422A and 105039T-105058A,
105584C-105604G and 106080G-106099G, 107094C-
107113A and 107518G-107537C, 107737G-107756C
and 108066C-108085C, 108524A-108543T and
109039G-109059T, and 109935G-109954G) and
110656G-110675C. Subsequently, PCR products were
purified and directly sequenced in both directions by dye
terminators into cycle-sequencing products.
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